Clostridioides difficile Infection Survey |
The Gastrointestinal Society and the Canadian Society of Intestinal Research represent patients on a variety of healthcare fronts. We have designed this survey to help us understand your opinions and outlook regarding the effects of recurrent Clostridioides difficile (C. diff or C. difficile) infection. We will use this information anonymously and in aggregate to shape future programming and to inform community members, healthcare professionals, and health policy decision-makers.
Most people who are infected with C. difficile receive antibiotics and get better. However, about 25% of these individuals develop a repeat of symptoms within two months. This is called a recurrence, and recurrences can repeat.
To complete this survey, you must meet one of the following criteria:
Most people who are infected with C. difficile receive antibiotics and get better. However, about 25% of these individuals develop a repeat of symptoms within two months. This is called a recurrence, and recurrences can repeat.
To complete this survey, you must meet one of the following criteria:
- person who has been infected with the C. difficile bacterium and/or experienced a recurrent C. difficile infection (within 8 weeks of initial infection)
- caregiver/loved one of a person who has been infected with the C. difficile bacterium and/or experienced a recurrent C. difficile infection, but not in a healthcare provider capacity
The physicians overseeing this survey are:
Ted Steiner, MD; Vancouver, BC
Susan M. Poutanen, MD, MPH, FRCPC; Toronto, ON